Literature DB >> 25494375

Late diagnosis and surgical treatment of patients diagnosed with unilateral congenital cataract at Fundación Visión, in Asuncion, Paraguay.

Manuel Zegarra1, Gisella Harumi Burga1, Van Lansingh2, Margarita Samudio3, Edgar Duarte1, Rocio Ferreira1, Yesenia Dorantes1, Juan Carlos Ginés1, Luz Zepeda4.   

Abstract

Purpose: Providing data on the late diagnosis and surgical treatment of patients who underwent surgery for total unilateral congenital cataract.
Methods: Systematic retrospective review of the medical record of all patients between 0 and 16 years old with total unilateral congenital cataract who underwent surgery at Fundación Vision between January 2010 and July 2012.
Results: Medical records of 37 patients (51 % females) were studied, age was 7.4 (± 4.9) years (average ± SD) and 62% lived on Departamento Central (the most populated region from Paraguay). A total of 97.3% patients underwent late surgical treatment and 86.5% received a late diagnosis. The average time elapsed between the diagnosis and the surgical treatment was one month, and 62.2% of the patients underwent surgery within six months from the diagnosis.
Conclusion: This study evidences that most of the patients in our series had a late treatment as a result of a late diagnosis. Based on these results we recommend establishing strategies to improve the early detection and surgical treatment of the newborns.

Entities:  

Year:  2014        PMID: 25494375     DOI: 10.5935/0004-2749.20140075

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  2 in total

Review 1.  MicroRNAs: new players in cataract.

Authors:  Xin Yu; Heyi Zheng; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

2.  Comparison between Limbal and Pars Plana Approaches Using Microincision Vitrectomy for Removal of Congenital Cataracts with Primary Intraocular Lens Implantation.

Authors:  Xin Liu; Tianyu Zheng; Xingtao Zhou; Yi Lu; Peng Zhou; Fan Fan; Yi Luo
Journal:  J Ophthalmol       Date:  2016-05-30       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.